Semaglutide – 10MG

Why Buy Semaglutide?

Researchers buy Semaglutide because it is one of the best-studied peptides for blood sugar control, appetite, and weight. In a large trial, people lost about 15% of their body weight over 68 weeks.^[1] Semaglutide is a GLP-1 receptor agonist. It is the active peptide in the drugs Ozempic® and Wegovy®.

It has years of clinical data behind it. That makes it a very well-documented GLP-1 tool for research models.

Semaglutide Benefits & Uses

Semaglutide is studied for metabolism, appetite, and weight. Here are the main research uses:

• GLP-1 receptor activity, appetite, and fullness research^[1]
• Blood sugar control and insulin release
• Belly fat and body weight reduction models^[1]
• Heart and metabolic risk factor research
• Stomach emptying and gut movement studies
• Comparison with multi-target peptides (Tirzepatide, Retatrutide)
• Fatty liver (NAFLD) models

How Semaglutide Works

Semaglutide works by turning on the GLP-1 receptor on cells in the pancreas. This helps release insulin when blood sugar is high and lowers glucagon, so blood sugar drops without much risk of going too low.^[1] In the brain, the same receptor lowers appetite and food intake. It also slows how fast the stomach empties, so the feeling of fullness lasts longer. Because it binds to albumin in the blood, it has about a 7-day half-life, which fits a once-weekly schedule in research.^[2]

Semaglutide 10mg Vial Specifications

• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
• Molecular Weight: 4,113.6 Da
• Purity: ≥99% (third-party HPLC verified)
• Form: Lyophilized (freeze-dried) powder
• Vial Size: 10 mg
• Storage: −20 °C (long-term); 4 °C (short-term)
• Reconstitution: Bacteriostatic water

Semaglutide Canada FAQs

Is Semaglutide the same as Ozempic?

Ozempic and Wegovy are brand-name drug versions of Semaglutide. They use the same active peptide. This research-grade vial is supplied for laboratory use only.

How does Semaglutide compare to Tirzepatide?

Semaglutide hits one target, the GLP-1 receptor. Tirzepatide adds a second target (GIP). Retatrutide adds a third (glucagon). In clinical data, the triple-target Retatrutide gives the largest weight drops, which makes the comparison useful for metabolic research.

Is Semaglutide available in Canada for research?

Yes. Reviv Peptides supplies Semaglutide in Canada as a 10 mg vial for laboratory research only.

Reconstitution & Dosing Guide

How to Reconstitute

Add 3.0 mL of bacteriostatic water to the vial. Inject the water slowly down the inside wall of the vial — do not inject directly onto the powder. Gently swirl until fully dissolved; do not shake. This yields about 3.33 mg/mL. Store the mixed vial at 4 °C and use within 28 days.

Low Starting Amount (Research)

• Amount per measure: 250 mcg — 7.5 units (0.075 mL) on a U-100 insulin syringe
• Schedule: Once weekly in research models (same day each week)
• Study length: 16+ weeks (raise the amount slowly)

Weeks 1–4 use the starting amount; raise slowly as the model allows.

This product is for laboratory research only. It is not for human or animal use.

Sources: [1] Wilding et al., Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1, NEJM 2021) — PubMed. [2] Weight regain after withdrawal of semaglutide (STEP 1 extension) — PMC.